
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Mochida Pharmaceutical Company, Ltd."
Count: 18
Selected: 0
NCT ID | Title |
---|
NCT04239950 | Efficacy of Ethyl Icosapentate in Patients With Severe Hypertriglyceridemia | ||
NCT03350386 | Drug-drug Interaction Study of FYU-981 and Oxaprozin | ||
NCT04345471 | A Study of MD-120 in Patients With Depression | ||
NCT03375632 | Study of FYU-981 in Hyperuricemic Outpatients With or Without Gout (Effect on Two Hyperuricemic Types) | ||
NCT03372200 | Febuxostat-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout | ||
NCT03306667 | Clinical Pharmacology of FYU-981 (Subjects With Hepatic Insufficiency) | ||
NCT03350373 | Clinical Pharmacology of FYU-981 (Final Formulation) | ||
NCT04221217 | Long-term Safety and Efficacy Study of MND-2119 in Patients With Hypertriglyceridemia | ||
NCT03693131 | Efficacy of MND-2119 in Participants With Hypertriglyceridemia | ||
NCT02052895 | Utility of Presepsin in Distinguishing Between Sepsis and SIRS | ||
NCT01154985 | Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH) | ||
NCT00960180 | Study Evaluating Single Ascending Doses of MR1817 | ||
NCT03006445 | Study of FYU-981 in Hyperuricemia With or Without Gout | ||
NCT03100318 | Benzbromarone-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout | ||
NCT02901366 | Mass Balance Study of FYU-981 | ||
NCT02746380 | A Study Comparing LBAL to Humira® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy | ||
NCT02357069 | A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy | ||
NCT00231738 | Protective Effect of EPA on Cardiovascular Events |